Search results
Psychoactive drugs are having a moment: The FDA will soon weigh in
Medical Xpress· 2 days agoLori Tipton is among the growing number of people who say that MDMA, also known as ecstasy, saved...
Not all sunflowers follow the sun — which is still intact.
Politifact· 2 days agoA field of sunflowers can be a cheerful sight, but recent social media posts suggest the distinctive...
State police lieutenant, forensic scientists testify as Karen Read murder trial resumes - Boston...
7 News Boston· 2 days agoState police Lt. Kevin O’Hara was the first new witness on the stand. While testimony continued, the...
Ipsen presents long-term elafibranor efficacy and itch-related quality of life data in patients with...
Benzinga· 14 hours agoNew data from the ELATIVE® Phase III trial show 70% of patients treated with elafibranor achieved composite endpoint of slowing disease progression measured by biochemical response after 78-weeksData from the itch
Mexico's new president is a climate scientist. That could be a boon for California.
Politico· 2 days agoGov. Gavin Newsom was among the California officials sharing snaps of themselves Monday with Sheinbaum, a former Mexico City mayor who has California ties. As a Ph.D. candidate in the 1990s, ...
State police lieutenant, forensic scientist testify as Karen Read murder trial resumes - Boston...
7 News Boston· 2 days agoState police Lt. Kevin O’Hara was the first new witness on the stand. The prosecution introduced...
Calviri Announces Completion of Groundbreaking Preventative Canine Cancer Vaccine Trial
Valley City Times Record· 2 days agoCalviri, Inc. announced the successful conclusion of the Vaccine Against Canine Cancer Study (VACCS)...
Psychoactive drugs are having a moment. The FDA will soon weigh in
The Desert Sun via Yahoo News· 7 days ago“It does seem that some of these molecules can be administered safely,” said David Olson, director of the University of California-< ...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 13 hours agoNew data from the ELATIVE® Phase III trial show 70% of patients treated with elafibranor achieved composite endpoint of slowing disease progression measured by biochemical response after 78-weeksData from the itch domain of the PBC-40 and 5-D
Americans don’t want lab-grown meat shoved down their throats
The Hill· 6 days agoActivist investor Ari Nessel recently wrote a piece in The Hill criticizing Florida for banning the...
